コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 in the treatment of side effects induced by antilymphocyte antibodies.
3 tomegalovirus (CMV) and who are treated with antilymphocyte antibody (ALA) therapy have a high rate o
5 e were fewer episodes of rejection requiring antilymphocyte antibodies and fewer study discontinuatio
9 atal grafts could be supported by monoclonal antilymphocyte antibodies, B10.A(5R) recipients were imm
14 an adult study population; (2) assessment of antilymphocyte antibodies in the immediate posttransplan
15 renal allografts who did and did not receive antilymphocyte antibodies in the perioperative period we
16 have not shown that the perioperative use of antilymphocyte antibodies (induction therapy) improves s
19 tors, antitumor necrosis factor-alpha drugs, antilymphocyte antibodies, or chemotherapeutic agents),
20 tithymocyte globulins (AThG) are a subset of antilymphocyte antibody preparations derived from the se
22 ulin (IVIG) in the treatment of steroid- and antilymphocyte antibody-resistant rejection in renal tra
27 were fewer CsA-NL patients (6.9%) requiring antilymphocyte antibody therapy for rejection than in th
28 reduced number of CsA-NL patients requiring antilymphocyte antibody therapy for rejection, fewer Int
30 ravenous ganciclovir for the duration of any antilymphocyte antibody therapy, in our kidney and simul
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。